# Cardinal Health, Inc. (CAH) FY2026 Annual P&L / Income Statement

- Company: Cardinal Health, Inc. (CAH)
- Period: 2025-07-01 to 2026-06-30
- Filing: FY2026 10-K, filed 2026-08-11, accession number 0000721371-26-000038
- Page: https://plicit.ai/financials/cah/fy2026-annual-income-statement
- Chart image: https://plicit.ai/charts/cah-fy2026-annual-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2025-07-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 254,248,000,000 US dollars
- **Cost of products sold**: 244,474,000,000 US dollars
- **Gross margin**: 9,774,000,000 US dollars
- **Operating costs, net of other operating items (calculated)**: 7,161,000,000 US dollars
- **Operating earnings**: 2,613,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 439,000,000 US dollars
- **Earnings before income taxes**: 2,174,000,000 US dollars
- **Income Tax Expense (Benefit)**: 469,000,000 US dollars
- **Net earnings**: 1,705,000,000 US dollars
- **GMPD**: 12,719,000,000 US dollars
- **Other Operating Segment**: 6,792,000,000 US dollars
- **Pharmaceutical and Specialty Solutions**: 234,833,000,000 US dollars
- **Distribution, selling, general, and administrative expenses**: 6,132,000,000 US dollars
- **Restructuring and employee severance**: 106,000,000 US dollars
- **Amortization and other acquisition-related costs**: 469,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs [Line Items]**: 287,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: 177,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 10,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 254,344,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Segment Reporting, Reconciling Item, Corporate Nonsegment**: negative 96,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **GMPD costs**: 12,461,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Other Operating Segment costs**: 6,085,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Pharmaceutical and Specialty Solutions costs**: 232,050,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 1,039,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.71 B; to noncontrolling interests: −$9.00 M.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/cah/fy2026-annual-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/cah-fy2026-annual-revenue-by-geography-sankey.png

Income statement for 2025-07-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 254,248,000,000 US dollars
- **Cost of products sold**: 244,474,000,000 US dollars
- **Gross margin**: 9,774,000,000 US dollars
- **Operating costs, net of other operating items (calculated)**: 7,161,000,000 US dollars
- **Operating earnings**: 2,613,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 439,000,000 US dollars
- **Earnings before income taxes**: 2,174,000,000 US dollars
- **Income Tax Expense (Benefit)**: 469,000,000 US dollars
- **Net earnings**: 1,705,000,000 US dollars
- **Non-US**: 1,705,000,000 US dollars
- **UNITED STATES**: 252,639,000,000 US dollars
- **Distribution, selling, general, and administrative expenses**: 6,132,000,000 US dollars
- **Restructuring and employee severance**: 106,000,000 US dollars
- **Amortization and other acquisition-related costs**: 469,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs [Line Items]**: 287,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: 177,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 10,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 254,344,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Components above reported revenue (calculated)**: negative 96,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.71 B; to noncontrolling interests: −$9.00 M.